Free Trial

Rayonier (RYN) Competitors

Rayonier logo
$24.38 +0.84 (+3.55%)
Closing price 03:58 PM Eastern
Extended Trading
$24.36 -0.03 (-0.10%)
As of 04:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

RYN vs. PCH, BCC, KIM, WY, OHI, CUBE, RHP, HR, EPR, and SBRA

Should you be buying Rayonier stock or one of its competitors? The main competitors of Rayonier include Potlatch (PCH), Boise Cascade (BCC), Kimco Realty (KIM), Weyerhaeuser (WY), Omega Healthcare Investors (OHI), CubeSmart (CUBE), Ryman Hospitality Properties (RHP), Healthcare Realty Trust (HR), EPR Properties (EPR), and Sabra Healthcare REIT (SBRA).

Rayonier vs. Its Competitors

Potlatch (NASDAQ:PCH) and Rayonier (NYSE:RYN) are both mid-cap construction companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, dividends, media sentiment, valuation and analyst recommendations.

Potlatch has a beta of 1.14, meaning that its share price is 14% more volatile than the S&P 500. Comparatively, Rayonier has a beta of 1.02, meaning that its share price is 2% more volatile than the S&P 500.

Rayonier has a net margin of 30.09% compared to Potlatch's net margin of 4.35%. Rayonier's return on equity of 3.29% beat Potlatch's return on equity.

Company Net Margins Return on Equity Return on Assets
Potlatch4.35% 2.36% 1.46%
Rayonier 30.09%3.29%1.74%

86.1% of Potlatch shares are owned by institutional investors. Comparatively, 89.1% of Rayonier shares are owned by institutional investors. 1.0% of Potlatch shares are owned by insiders. Comparatively, 0.8% of Rayonier shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Rayonier had 2 more articles in the media than Potlatch. MarketBeat recorded 21 mentions for Rayonier and 19 mentions for Potlatch. Rayonier's average media sentiment score of 1.05 beat Potlatch's score of 0.26 indicating that Rayonier is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Potlatch
4 Very Positive mention(s)
3 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Rayonier
9 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Rayonier has higher revenue and earnings than Potlatch. Rayonier is trading at a lower price-to-earnings ratio than Potlatch, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Potlatch$1.06B3.09$21.88M$0.6168.51
Rayonier$1.26B3.01$359.15M$2.3310.47

Potlatch currently has a consensus price target of $50.00, suggesting a potential upside of 19.65%. Rayonier has a consensus price target of $27.75, suggesting a potential upside of 13.80%. Given Potlatch's stronger consensus rating and higher probable upside, equities research analysts clearly believe Potlatch is more favorable than Rayonier.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Potlatch
0 Sell rating(s)
0 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
3.00
Rayonier
0 Sell rating(s)
3 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.25

Potlatch pays an annual dividend of $1.80 per share and has a dividend yield of 4.3%. Rayonier pays an annual dividend of $1.09 per share and has a dividend yield of 4.5%. Potlatch pays out 295.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Rayonier pays out 46.8% of its earnings in the form of a dividend. Rayonier is clearly the better dividend stock, given its higher yield and lower payout ratio.

Summary

Rayonier beats Potlatch on 11 of the 18 factors compared between the two stocks.

Get Rayonier News Delivered to You Automatically

Sign up to receive the latest news and ratings for RYN and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RYN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RYN vs. The Competition

MetricRayonierBLDG PRD IndustryConstruction SectorNYSE Exchange
Market Cap$3.80B$10.02B$9.39B$20.82B
Dividend Yield4.63%2.25%2.06%3.65%
P/E Ratio10.4726.3916.1327.78
Price / Sales3.012.03107.8555.34
Price / Cash16.7013.5514.8117.94
Price / Book2.042.544.544.65
Net Income$359.15M$297.37M$620.50M$993.55M
7 Day Performance4.93%3.21%2.56%2.22%
1 Month Performance8.21%5.80%5.10%7.67%
1 Year Performance-17.34%-14.55%97.13%12.22%

Rayonier Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RYN
Rayonier
4.2712 of 5 stars
$24.39
+3.5%
$27.75
+13.8%
-19.5%$3.80B$1.26B10.47420Positive News
Dividend Announcement
PCH
Potlatch
4.2957 of 5 stars
$40.50
-0.2%
$48.86
+20.6%
-3.8%$3.18B$1.10B66.391,383Upcoming Earnings
BCC
Boise Cascade
4.8093 of 5 stars
$89.50
-1.8%
$120.17
+34.3%
-36.2%$3.37B$6.62B11.177,560Analyst Revision
KIM
Kimco Realty
3.9452 of 5 stars
$21.71
+1.0%
$24.70
+13.8%
+1.8%$14.68B$2.07B28.19640Positive News
WY
Weyerhaeuser
4.2292 of 5 stars
$25.90
-1.6%
$33.13
+27.9%
-16.8%$18.78B$7.12B51.799,440Upcoming Earnings
Analyst Forecast
OHI
Omega Healthcare Investors
3.499 of 5 stars
$38.38
+2.2%
$42.25
+10.1%
+5.9%$11.11B$1.08B23.8450Positive News
CUBE
CubeSmart
3.835 of 5 stars
$42.18
-0.4%
$47.38
+12.3%
-14.5%$9.61B$929.08M24.963,104Positive News
RHP
Ryman Hospitality Properties
3.9643 of 5 stars
$103.77
+0.5%
$114.43
+10.3%
-3.4%$6.23B$2.40B21.981,929Positive News
Analyst Forecast
HR
Healthcare Realty Trust
3.5428 of 5 stars
$16.00
-0.7%
$16.40
+2.5%
-7.2%$5.62B$1.27B-14.67580Positive News
EPR
EPR Properties
3.6878 of 5 stars
$61.20
+1.4%
$56.43
-7.8%
+33.0%$4.66B$649.20M37.5460Dividend Announcement
SBRA
Sabra Healthcare REIT
1.2199 of 5 stars
$18.76
+1.6%
$19.67
+4.8%
+10.2%$4.46B$703.23M31.8040Positive News

Related Companies and Tools


This page (NYSE:RYN) was last updated on 7/22/2025 by MarketBeat.com Staff
From Our Partners